Ghrelin, an endogenous peptide isolated from the stomach, is known to stimulate food intake after peripheral administration. We found that the enzymatic digest of b-lactoglobulin decreases ghrelin secretion from the ghrelin-producing cell line MGN3-1. The peptides present in the digest were comprehensively analyzed using the nanoLC-OrbitrapMS. Among them, we identified that the nonapeptide LIVTQTMKG, corresponding to b-lactoglobulin(1-9), suppresses ghrelin secretion from MGN3-1 cells. We named LIVTQTMKG 'lacto-ghrestatin'. We found that lacto-ghrestatin decreases intracellular cAMP levels and mRNA expression levels of ghrelin production-related genes in MGN3-1 cells. Orally administered lacto-ghrestatin decreases plasma ghrelin levels and food intake in fasted mice. Lacto-ghrestatin is the first food-derived peptide to suppress ghrelin secretion in vitro and in vivo.
Ghrelin, a 28-amino acid peptide hormone isolated from the stomach, stimulates food intake, gastric motility, and growth hormone release after peripheral administration [1] [2] [3] . The secretion of ghrelin is known to be stimulated by fasting and suppressed after feeding [4] [5] [6] [7] . By utilizing recently established ghrelinsecreting cell lines, it has been uncovered that several endogenous factors, such as norepinephrine, insulin, and somatostatin, also regulate ghrelin secretion [8, 9] .
The first example of bioactive peptide derived from food protein is b-casomorphin-7, an opioid peptide found from the digest of milk protein [10] . Currently, a number of low molecular weight bioactive peptides have been found from the protease hydrolysate of several food proteins including milk protein [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Recently, our group has reported the first exogenous ghrelin-releasing peptide derived from food protein [20] . In this study, we focused on exogenous peptides that exhibited ghrelin secretion-lowering activity, which may contribute to suppressing food intake and/ or preventing obesity. We investigated the effects of the enzymatic digest of b-lactoglobulin, a major protein of bovine milk whey, on ghrelin secretion. We then found that the digest of b-lactoglobulin treated with thermolysin, a microorganism-derived enzyme used for food processing at an industrial scale, Abbreviations DMEM, Dulbecco's modified Eagle's medium; DPBS, Dulbecco's phosphate-buffered saline; ESI, electrospray ionization; GOAT, ghrelin Oacyl transferase; HPLC, high-performance liquid chromatography; nanoLC-MS, nano-flow liquid chromatograph-Fourier transform ion cyclotron resonance mass spectrometer; PC1/3, prohormone convertase 1/3; QTOF, quadrupole time-of-flight; SDB, styrene divinylbenzene; UPLC, ultra-high-performance liquid chromatography.
decreased ghrelin secretion from MGN3-1, the ghrelinsecreting cell line [8] .
We comprehensively analyzed peptides present in the thermolytic digest of b-lactoglobulin using a nano-flow liquid chromatograph-Fourier transform ion cyclotron resonance mass spectrometer (nanoLC-MS), and synthesized candidate peptides. Among them, LIVTQTMKG (termed 'lacto-ghrestatin'), corresponding to 1-9 of b-lactoglobulin, suppressed ghrelin secretion from MGN3-1 cells. We also investigated whether intracellular second messengers were modulated in response to lacto-ghrestatin since somatostatin and fatty acids were reported to suppress ghrelin secretion through the inhibitory regulative G-protein (G i ) signaling pathway [21, 22] . Ghrelin is synthesized as the prohormone preproghrelin, followed by acylation at Ser 3 by the intracellular enzyme ghrelin O-acyl transferase (GOAT) and cleavage by prohormone convertase 1/3 (PC1/3). We examined whether lactoghrestatin affects the mRNA expression of preproghrelin, GOAT or PC1/3 genes.
We also investigated the in vivo effects of lactoghrestatin on plasma ghrelin levels after oral administration in fasted or nonfasted mice. We also examined whether orally administered lacto-ghrestatin suppressed food intake.
Materials and methods

Reagents
Leu-Ile-Val-Thr-Gln-Thr-Met-Lys-Gly (LIVTQTMKG), Leu-Asp-Ile-Gln-Lys (LDIQK), Ile-Asp-Ala-Leu-Asn-GluAsn-Lys-Val (IDALNENKV), Leu-Val-Arg-Thr-Pro-Glu-
Val-Arg-Thr-Pro-Glu-Val-Asp-AspGlu-Ala (VRTPEVDDEA), Leu-Val-Leu-Asp-Thr-As p-Tyr-Lys-Lys-Tyr (LVLDTDYKKY), Leu-Val-Leu-AspThr-Asp-Tyr-Lys-Lys (LVLDTDYKK), Ile-Ile-Ala-GluLys-Thr-Lys-Ile-Pro-Ala (IIAEKTKIPA), and Leu-Ly s-Pro-Thr-Pro-Glu-Gly-Asp-Leu-Glu (LKPTPEGDLE) were synthesized by the F-moc strategy and were purified by reverse-phase high-performance liquid chromatography (HPLC). Sodium octanoate was purchased from SigmaAldrich. (St. Louis, MO, USA). Forskolin was purchased from Enzo Life Sciences (Farmingdale, NY, USA). Thermolysin, the microbial enzyme derived from Bacillus thermoproteolyticus, was purchased from Amano Enzyme (Nagoya, Japan).
Cell culture
The ghrelin-producing cell line, MGN3-1, from a gastric ghrelinoma derived from ghrelin promoter SV40-T antigen transgenic mice, was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 UÁmL À1 penicillin, and 100 lgÁmL À1 streptomycin at 37°C in 10% CO 2 , as previously described [8] .
Enzymatic digestion of b-lactoglobulin b-Lactoglobulin (Sigma Aldrich) was dissolved in water at the concentration of 20 mgÁmL
À1
. Enzymatic digestion by thermolysin (enzyme: substrate ratio = 1 : 100) was performed at 37°C for 5 h (pH 7.5). After being boiled for 10 min to inactivate the enzyme, the digest was freeze-dried and kept at À20°C until the experiments.
Comprehensive peptide analysis of the enzymatic digest using the nanoLC-MS . During the separation, the flow rate and the column temperature were kept at 300 nLÁmin À1 and 40°C, respectively. The digests were then ionized by electrospray ionization and analyzed by the mass spectrometer in positive ion mode. The precursor ion was monitored at the resolving power of 60 000 in mass range from 200 to 1500 by an Orbitrap detector. The divalent or trivalent precursor ions with top five intensities in the scan were dissociated by collision energy dissociation and the fragment ions were monitored by a linear ion trap detector for MS 2 spectrum. The sequences of peptides detected were estimated in silico by PROTEOME DISCOVERER 1.4 (Thermo Fischer Scientific) using protein sequences of blactoglobulin deposited in National Center for Biotechnology Information as reference sequences.
Quantitative ultra-high-performance liquid chromatography-mass spectrometry (UPLC/MS)
The quantitative peptide analysis of enzymatic digests of blactoglobulin was performed as described previously [20] . Briefly, an Acquity ultra-high-performance liquid chromatography (UPLC) system (Waters, Milford, MA, USA) coupled to a Xevo quadrupole time-of-flight (QTOF) mass spectrometer (Waters) equipped with an electrospray ionization (ESI) was used. The mobile phases consisted of 0.1% formic acid in water (solvent A) and 0.1% formic acid in acetonitrile (solvent B). Separation was performed with a linear gradient of solvent B from 0% to 40% (v/v) for 5 min at a flow rate of 0.4 mLÁmin À1 using an Acquity BEH-C 18 reversed-phase column (Waters). We used synthetic peptides as standards.
In vitro experiment on ghrelin secretion in MGN3-1 cells
Acylated ghrelin concentrations in culture media of MGN3-1 cells were measured as described previously [20] . Briefly, MGN3-1 cells were washed with Dulbecco's phosphate-buffered saline (DPBS) and incubated with chemicals dissolved in DMEM containing 50 lM sodium octanoate at 37°C for 4 h. The collected culture media were centrifuged at 800 g for 5 min at 4°C. The supernatant was acidified with 10% v/v of 1 N HCl, and stored at À80°C until analysis. To measure the cellular ghrelin content, MGN3-1 cells were lysed with RIPA buffer containing 19 protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan) after washing with ice-cold DPBS. The cell lysate was incubated on ice for 30 min, and then centrifuged at 12 000 g for 10 min at 4°C. The resulting supernatant was acidified with 10% v/v of 1 N HCl, and stored at À80°C until analysis. Ghrelin concentrations in samples were determined using an acylated ghrelin enzyme immunoassay kit (Bertin Pharma, Montigny le Bretonneux, France) according to the manufacturer's guidelines.
Intracellular cAMP and Ca 2+ levels
Cyclic AMP and Ca 2+ levels in MGN3-1 cells were measured as described previously [20] . For cAMP measurement, cells were incubated with chemicals dissolved in Krebs-Ringer-HEPES buffer (110 mM NaCl, 5 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 55 mM sucrose, 25 mM glucose, 10 mM HEPES, pH 7.4) containing 500 lM 3-isobutyl-1-methylxanthine at 37°C for 30 min. The intracellular cAMP concentration was determined using a HitHunter cAMP Assay for Small Molecules kit (DiscoveRx, Fremont, CA, USA). For Ca 2+ measurement, cells were loaded with fluo-4-AM using the Calcium Kit II-Fluo 4 (Dojindo Laboratories, Kumamoto, Japan). After a 1-h incubation, the cell plates were placed into a POLARstar OPTIMA (BMG LABTECH GmbH, Ortenberg, Germany) to monitor cell fluorescence (k ex = 485 nm, k em = 520 nm) before and after the application of the test compounds.
RNA preparation from MGN3-1 cells and quantitative RT-PCR
Total RNA was extracted using the RNeasy Mini Kit (QIA-GEN, Hilden, Germany) and reverse transcribed using the Takara PrimeScript RT Master Mix (Takara, Osaka, Japan) as directed by the manufacturer. For quantitative PCR, we amplified the cDNA using Applied Biosystems Prism 7000 Sequence Detection System (Foster City, CA, USA) with Platinum SYBER Green qPCR SuperMix-UDG with ROX solution (Invitrogen, Carlsbad, CA, USA) and each primer set specific for mouse b-actin, preproghrelin, GOAT or PC1/ 3, according to the manufacturer's instructions ( Table 1) . The reactions were cycled 40 times with denaturation at 95°C for 15 s, and with annealing and elongation at 60°C for 30 s. The relative expression level of each mRNA was normalized using the mRNA level of b-actin.
Effect on ghrelin levels and food intake in vivo
Measurement of plasma ghrelin levels was performed with slight modification to the previously described method [20] . Briefly, 11-weeks-old male ddY mice (Japan SLC, Shizuoka, Japan) were deprived of food pellets for 18 h in the case of fasting conditions. Lacto-ghrestatin dissolved in saline was orally administered to mice. Food pellets were removed at this time in the case of nonfasting conditions. After 60 min, mice were anesthetized and immediately blood was collected from the orbital sinus. Blood was centrifuged at 1120 g for 10 min at 4°C, and the supernatant was acidified with 10% v/v of 1 N HCl before storing at À80°C. Ghrelin concentrations were determined using an acylated ghrelin enzyme immunoassay kit. For food intake measurement, individually housed 8-week-old male ddY mice were deprived of food pellets for 18 h. Lacto-ghrestatin dissolved in saline was orally administered to mice and food pellets were given. After 4 h, the weight of the diet was measured and food intake was calculated. All experiments were approved by the Kyoto University animal committee.
Statistical analysis
The difference between two groups was assessed by Student's t-test. To assess differences among more than three groups, analysis of variance (ANOVA) followed by TukeyKramer's test was used. P-values < 0.05 were considered significant.
Results
Identification of lacto-ghrestatin, a novel nonapeptide suppressing ghrelin secretion, from thermolytic digest of b-lactoglobulin
To investigate the effects of enzymatic digests of the major bovine milk protein b-lactoglobulin on ghrelin secretion, we used MGN3-1, a recently established ghrelin-producing cell line [8] , and measured acylated ghrelin, an active form necessary for physiological action of ghrelin, in the culture medium. The thermolytic digest of b-lactoglobulin decreased acylated ghrelin levels of the medium in a dose-dependent manner (Fig. 1) . Next, we performed comprehensive peptide analysis of the digest using a nanoLC-MS. One hundred thirtyseven peptide fragments derived from b-lactoglobulin were detected, and sorted in order of precursor ion intensity, which roughly related to the peptide content (Table S1 ). Among them, we chemosynthesized 10 peptides, recorded highest precursor ion intensity, and investigated whether these candidate peptides suppressed ghrelin secretion. We found that LIVTQTMKG, corresponding to b-lactoglobulin(1-9), decreased acylated ghrelin concentrations in the culture medium of MGN3-1 cells (Fig. 2A) . The inhibitory effect of LIVTQTMKG on ghrelin secretion exhibited dose-dependency, and the minimum effective dose was 10 lM (Fig. 3) . We quantified LIVTQTMKG in the thermolytic digest by using the UPLC/MS system and synthetic standard peptides. The content was 15.1 mgÁg À1 (estimated 27.9 mol%), indicating that LIVTQTMKG was released by thermolytic digestion of b-lactoglobulin. We then named LIVTQTMKG 'lacto-ghrestatin' (Fig. 2B) .
Lacto-ghrestatin decreased intracellular cAMP levels stimulated by forskolin
To investigate intracellular signaling of lacto-ghrestatin, we measured changes in cAMP and Ca 2+ levels in MGN3-1. We focused on the G i signaling because a few ghrelin secretion-suppressing factors, insulin and somatostatin, were reported to activate the G i pathway [21] [22] [23] . When lacto-ghrestatin (100 or 300 lM) and forskolin (10 lM) were applied to MGN3-1 cells, the intracellular cAMP levels were decreased when compared with forskolin alone (Fig. 4A) . These results suggest that lacto-ghrestatin suppresses forskolin-stimulated intracellular cAMP elevation, similar to endogenous ghrelin secretion-suppressing factors.
In contrast, lacto-ghrestatin did not affect the intracellular Ca 2+ levels (Fig. 4B) , implying that it suppresses ghrelin secretion independently of the Ca 2+ signaling pathway.
Lacto-ghrestatin decreased gene expression related with ghrelin synthesis and intracellular ghrelin levels
To investigate the effects of lacto-ghrestatin on ghrelin production, we measured the levels of preproghrelin, GOAT and PC1/3 mRNA expression in MGN3-1. Using RT-PCR, we found that lacto-ghrestatin (300 lM) and the thermolytic digest of b-lactoglobulin (10 mgÁmL À1 ) decreased the expression levels of these mRNA (Fig. 5A-C) . Moreover, lacto-ghrestatin (300 lM) and the digest (10 mgÁmL À1 ) decreased the intracellular ghrelin levels (Fig. 5D ). These results suggest that lacto-ghrestatin as well as the thermolytic digest of b-lactoglobulin suppresses ghrelin production.
Orally administered lacto-ghrestatin decreased ghrelin secretion and food intake in mice
To clarify the in vivo effects of lacto-ghrestatin, we performed experiments using mice. Blood ghrelin levels have been reported to elevate by fasting and decrease Table 1 . Oligonucleotide sequence of PCR primers specific for preproghrelin, GOAT, PC1/3, and b-actin. in response to feeding. Indeed, we confirmed that plasma acylated ghrelin levels in fasted mice were higher than that of non-fasted mice (Fig. 6 ). Orally administered lacto-ghrestatin decreased ghrelin levels increased by fasting at a dose of 1 mgÁkg À1 (Fig. 6A ).
On the other hand, lacto-ghrestatin did not affect basal ghrelin levels without fasting (Fig. 6B) . Next, we investigated whether lacto-ghrestatin decreased food intake, since ghrelin exhibits orexigenic effects. Orally administered lacto-ghrestatin decreased food intake at a dose of 1 mgÁkg À1 in fasted mice (Fig. 6C) . These results suggest that lacto-ghrestatin is orally active in fasted mice. Taken together, we demonstrated that lacto-ghrestatin, which inhibits ghrelin secretion from MGN3-1 cells, decreased Lacto-ghrestatin Lacto-ghrestatin (μM) Acylated ghrelin (% of control) Fig. 3 . Dose-dependency of lacto-ghrestatin on its ghrelin secretion suppressing effects. Ghrelin levels in the medium were measured 4 h after application. Values are mean AE SEM (n = 3-4). *P < 0.05 compared with the vehicle-control group. plasma ghrelin levels and food intake, thus mimicking ghrelin inhibitors.
Discussion
We found that the thermolytic digest of bovine b-lactoglobulin decreased ghrelin secretion from MGN3-1, the ghrelin-producing cell line originated from the mouse stomach. We also identified that LIVTQTMKG, a nonapeptide released by thermolysin from a milk whey protein, suppressed ghrelin secretion. This peptide, named lacto-ghrestatin, is the first example of a ghrelin secretion-suppressing peptide derived from food protein. In addition, ghrelin secretion was suppressed by the digest of thermolysin, but not subtilisin or sumizyme, microorganism-derived enzymes with substrate specificities different from that of thermolysin (data not shown). Indeed, lacto-ghrestatin was effectively released in the digest of thermolysin, but not in those of subtilisin or sumizyme (data not shown). We observed that a dipeptide LeuIle, lacto-ghrestatin(1-2), also decreased ghrelin secretion; however, the minimum effective dose of Leu-Ile was higher than that of full length lacto-ghrestatin (H. Aoki, J. Nakato, H. Iwakura, R. Kanamoto & K. Ohinata, unpublished observation). Further investigation will reveal where is important for the suppression of ghrelin secretion in the structure of lacto-ghrestatin. Lacto-ghrestatin also decreased unacylated ghrelin levels in the medium of MGN3-1 cells (Fig. S1 ) as well as that of acylated ghrelin, implying that it may nonselectively suppress secretion of both acylated and unacylated ghrelin, probably from the secretary granules.
Lacto-ghrestatin decreased intracellular cAMP levels elevated by forskolin stimulation. It was reported that G i -protein coupled receptors, including somatostatin and long chain fatty acid receptors, often mediated inhibitory effects on ghrelin secretion [21] . Thus, the unidentified target receptor of lacto-ghrestatin may be G i receptors.
Lacto-ghrestatin decreased the mRNA expression levels of genes related to ghrelin production and intracellular ghrelin levels. These results suggest that lactoghrestatin suppresses ghrelin production as well as its secretion. The agonist of GPR120, long-chain fatty acid sensing receptor, suppresses ghrelin secretion and decreases the mRNA expression of PC1/3 and intracellular ghrelin levels [24] . Our findings about lacto-ghrestatin are in accordance with that report. The agonist of GPR120, however, did not change the mRNA Values are mean AE SEM (A, n = 6; B, n = 4; C, n = 17). *P < 0.05 compared with the control group.
expressions of preproghrelin and GOAT. This dissimilarity may suggest that lacto-ghrestatin acts through different mechanisms from that of the agonist of GPR120. We found that orally administrated lacto-ghrestatin decreased plasma ghrelin levels in fasted mice. Ghrelin-producing cells in the gastrointestinal tract are classified into two groups with different morphological features; closed-type and opened-type cells [25] . Opened-type cells, which are predominantly observed in lower gastrointestinal tract, are considered to be functionally regulated by nutrient signals as they have direct contact to the intestinal lumen [25] . In this study, lacto-ghrestatin may act on this type of ghrelinproducing cells after oral administration. A recent study has shown that the long-chain fatty acid sensing receptor was colocalized with opened-type ghrelin cells in the duodenum, which played a role in the modulation of the ghrelin secretion by lipid-sensing [26] . Further research will elucidate the mechanism by which lacto-ghrestatin decreases ghrelin secretion in vivo.
It was reported that some endogenous hormones, including somatostatin, insulin and growth hormone, suppress ghrelin secretion [8, 27, 28] . Long chain fatty acids, such as a-linolenic acid, and glucose, which are food components or released during the postprandial period, also suppress ghrelin secretion [24, [29] [30] [31] [32] . A high-protein diet intake was reported to decrease plasma ghrelin levels [33, 34] ; however, active substances, probably several peptides released by gastrointestinal proteases, are not identified yet. After meals, blood ghrelin levels are known to decline. The potential contribution of exogenous factors, including peptides derived from proteins and proteins themselves, to the inhibitory effects on ghrelin secretion are expected to be uncovered in the future.
In conclusion, we identified lacto-ghrestatin, a novel nonapeptide derived from b-lactoglobulin, a major milk whey protein. We demonstrated that lacto-ghrestatin decreases ghrelin secretion in a G i signaling-dependent manner in ghrelin secreting MGN3-1 cells. Lacto-ghrestatin is an orally active peptide that decreases blood ghrelin levels and food intake in vivo. 
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